Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “ezetimibe”

4 pharma patents match "ezetimibe" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 4
Index total 30,257
Page 1 / 1

Quick answer

This filtered view shows 4 pharmaceutical patents matching "ezetimibe" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

4 results for “ezetimibe” · 30,257 patents in full index Clear search

  1. US 11744816

    Fixed dose combinations and formulations comprising ETC1002 and ezetimibe and methods of treating or reducing the risk of cardiovascular disease

    Esperion Therapeutics, Inc. · Granted Sep 5, 2023 · Expires Aug 31, 2043

    granted

  2. US 10912751

    Fixed dose combinations and formulations comprising ETC1002 and ezetimibe and methods of treating or reducing the risk of cardiovascular disease

    Esperion Therapeutics, Inc. · Granted Feb 9, 2021 · Expires Feb 4, 2041

    granted

  3. US 10905736

    Ezetimibe-associated ApoA-I mimetic peptides showing enhanced synergism

    The Regents of the University of California · Granted Feb 2, 2021 · Expires Jan 28, 2041

    granted

  4. US 9095515

    Ezetimibe compositions

    SANOVEL ILAC SANAYI VE TICARET ANONIM SIRKETI · Granted Aug 4, 2015 · Expires Jul 30, 2035

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.